Inhibitory effects of effective component in Zhimu on platelet aggregation in vitro and in vivo

Chinese Pharmacological Bulletin

Volumn 21, Issue 12, 2005, Pages 1460-1462

  Deng, Yun ^a   Ma, Bai Ping ^b   Xu, Qiu Ping ^c   Xiong, Cheng Qi ^b   Liu, Zhen Quan ^c   Zhao, Yang ^b   Zhang, Ai Lin ^c  

^a ANHUI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Compound 9714; In vitro; In vivo; Metabolite; Platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; COLLAGEN; COMPOUND 9714; UNCLASSIFIED DRUG; ZHIMU;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; RABBIT; THROMBOCYTE AGGREGATION; TURBIDIMETRY;

EID: 32344438219     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Del Zoppo GJ. The role of platelets in ischemic stroke[J]. Neurology, 1998, 51(Suppl 3):S9-14.
2. Bedar MM, Gross CE. Antiplatelet therapy in acute cerebral ischemia [J]. Stroke, 1999, 30(4):887-93.
3. Hoet B, Falcon C, De Reys S et al. R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet actibation in vitro and in vivo: a comparison with aspirin[J]. Blood, 1990, 75:646-53.